This post was originally published in 2012 and is part of an ongoing review of past posts about the conceptual boundaries of addiction and its relationship to the disease model and recovery. In a thoughtful post, Marc Lewis questions the disease model of addiction. He doesn't dismiss it out of hand. He seems to look … Continue reading Response to Why Addiction is NOT a Brain Disease
[This post was originally published in 2013.] I spent a little more time with Jim Contopulos' video memorial for his son and an interview he did will Bill White. There's a lot to all of this, but a couple of things stuck with me. In the interview, he discussed being a scared parent and seeking … Continue reading Care that never quits
This is a throwback post that was originally posted January 14, 2012. Some friends shared this video about the benefits of exercise: At about 7:00, he says: So a German researcher named Rainer Hambrecht looked at this with about 100 cardiac patients He got the group to exercise, and by that I mean 20 minutes … Continue reading Less effective and focused on only one problem
A new leader in the Open Society Institute shares a sensible perspective on reducing overdoses: Looking ahead, reducing drug overdoses will require major shifts in how we approach substance use. First, and possibly most importantly, Maryland needs to connect individuals struggling with addiction to high-quality addiction treatment that is integrated with their primary care. Primary care providers … Continue reading Reducing overdoses
A new book, The American Health Care Paradox: Why Spending More Is Getting Us Less, offers an interesting take on why the United States' huge investments in health care doesn't translate into better health. Vox did an interview with the book's authors. The paradox that we outline is one that a lot of readers will be … Continue reading Over-medicalization of health?
Bill White explaining why inadequate treatment may be worse than no treatment: What we know from primary medicine is that ineffective treatments (via placebo effects) or an inadequate dose of a potentially effective treatment (e.g., as in antibiotic treatment of bacterial infections) may temporarily suppress symptoms. Such treatments create the illusion of resumed health, but … Continue reading Personal Failure or System Failure?
The Health Affairs blog questions the American Heart Association's maximalist approach with the use of statins. The issues sound familiar. The policy implications of these guidelines are staggering. Estimates show that if these recommendations are fully implemented, close to a third of all Americans will be placed on a statin. But these developments beg the … Continue reading The Unintended Consequences Of Medical “Maximalism”
Anna David shares her 10th step work with us. One of my favorite things in recovery is that way many people with solid recovery share their 10th step stuff with us in a way that provokes laughter with them. This laughter, which in other contexts could be cutting or toxic, somehow fosters insight, fellowship and growth. … Continue reading Learning Non-Reaction in Recovery
This weekend is the fist time I recall seeing Bill White discuss the concept of community recovery capital. I've heard him discuss community recovery and the ecology of recovery, but I think I must have missed community recovery capital. The prognosis for community recovery is influenced by the ratio between problem prevalence, severity, and complexity … Continue reading Community Recovery Capital
Drugfree.org has a piece advocating more use of buprenorphine with children. Medication-Assisted Treatment (MAT) for opioid dependence is a science-based and proven-effective option for teens and young adults. It should be administered with age appropriate psychosocial therapy and drug testing. Unfortunately, it has been subject to controversy and stigma. Yet the neuroscience of addiction and … Continue reading Pediatric use of buprenorphine